MAb-3F8
3F8-NB-201
Phase 2 mab terminated
Quick answer
MAb-3F8 for Primary Refractory Neuroblastoma is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Primary Refractory Neuroblastoma
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated